These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8288878)

  • 1. Quantitative analysis of platelet-activating factor in human plasma. Application to patients with liver cirrhosis and disseminated intravascular coagulation.
    Sugatani J; Miwa M; Komiyama Y; Murakami T
    J Immunol Methods; 1993 Dec; 166(2):251-61. PubMed ID: 8288878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of a radioimmunoassay and bioassay for embryo-derived platelet-activating factor.
    Ammit AJ; O'Neill C
    Hum Reprod; 1991 Jul; 6(6):872-8. PubMed ID: 1757528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new method of purification and sensitive bioassay of platelet-activating factor (PAF) in human whole blood.
    Shinozaki K; Kawasaki T; Kambayashi J; Sakon M; Shiba E; Uemura Y; Ou M; Iwamoto N; Mori T
    Life Sci; 1994; 54(6):429-37. PubMed ID: 8295490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a novel scintillation proximity radioimmunoassay for platelet-activating factor measurement: comparison with bioassay and GC/MS techniques.
    Sugatani J; Lee DY; Hughes KT; Saito K
    Life Sci; 1990; 46(20):1443-50. PubMed ID: 2111868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of platelet activating factor (PAF) in human saliva. Quantitation by radioimmunoassay.
    Cooney SJ; Smal MA; Baldo BA
    Clin Chim Acta; 1991 Aug; 200(2-3):161-73. PubMed ID: 1777966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical study on the significance of platelet-activating factor in the pathophysiology of septic disseminated intravascular coagulation in surgery.
    Ono S; Mochizuki H; Tamakuma S
    Am J Surg; 1996 Apr; 171(4):409-15. PubMed ID: 8604832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and experimental studies on the role of platelet-activating factor (PAF) in the pathogenesis of septic DIC.
    Ono S; Tamakuma S; Mochizuki H; Kinoshita M; Ohkusa Y; Aosasa S; Oda Y; Ohe H
    Surg Today; 1993; 23(3):228-33. PubMed ID: 8467174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of platelet-activating factor and alkyl-ether phospholipids by gas chromatography-mass spectrometry via direct derivatization.
    Balazy M; Braquet P; Bazan NG
    Anal Biochem; 1991 Jul; 196(1):1-10. PubMed ID: 1888023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunoassay for platelet-activating factor.
    Karasawa K; Satoh N; Hongo T; Nakagawa Y; Setaka M; Nojima S
    Lipids; 1991 Dec; 26(12):1126-9. PubMed ID: 1819698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of PAF in blood by radioimmunoassay. Examination of interfering factors and problems involved in accurate quantification.
    Cooney SJ; Smal MA; Baldo BA
    J Immunol Methods; 1992 Jul; 151(1-2):131-8. PubMed ID: 1629604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible role of platelet activating factor (PAF) in disseminated intravascular coagulation (DIC), evidenced by use of a PAF antagonist, CV-3988.
    Imura Y; Terashita Z; Nishikawa K
    Life Sci; 1986 Jul; 39(2):111-7. PubMed ID: 3741541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of platelet-activating factor in a canine model of coronary thrombosis and in endarterectomy samples from patients with advanced coronary artery disease.
    Mueller HW; Haught CA; McNatt JM; Cui K; Gaskell SJ; Johnston DA; Willerson JT
    Circ Res; 1995 Jul; 77(1):54-63. PubMed ID: 7788882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of platelet-activating factor in biological samples using liquid chromatography/mass spectrometry with column-switching technique.
    Oda Y; Mano N; Asakawa N
    Anal Biochem; 1995 Oct; 231(1):141-50. PubMed ID: 8678293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of platelet activating factor treated with pentafluorobenzoyl chloride using gas chromatography/negative ion chemical ionization mass spectrometry.
    Shindo K; Hashimoto Y
    Drugs Exp Clin Res; 1991; 17(7):343-9. PubMed ID: 1794300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of plasma level of platelet activating factor in cirrhotic patients and its relation to endotoxemia].
    Zeng N
    Zhonghua Yi Xue Za Zhi; 1992 Mar; 72(3):141-3, 189. PubMed ID: 1319804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A specific, sensitive radioimmunoassay for platelet-activating factor (PAF).
    Smal MA; Baldo BA; McCaskill A
    J Immunol Methods; 1990 Apr; 128(2):183-8. PubMed ID: 2324511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased levels of blood platelet-activating factor (PAF) and PAF-like lipids in patients with ischemic stroke.
    Satoh K; Imaizumi T; Yoshida H; Hiramoto M; Takamatsu S
    Acta Neurol Scand; 1992 Feb; 85(2):122-7. PubMed ID: 1574985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of FR128998, a novel PAF receptor antagonist, on endotoxin-induced disseminated intravascular coagulation.
    Yokota Y; Inamura N; Asano M; Yamamoto Y; Nakahara K; Notsu Y; Ono T; Watanabe M
    Eur J Pharmacol; 1994 Jun; 258(3):239-46. PubMed ID: 8088357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related increase of plasma platelet-activating factor concentrations in Chinese.
    Zhang X; Yuan CL; Zhang HZ; Huang RX
    Clin Chim Acta; 2003 Nov; 337(1-2):157-62. PubMed ID: 14568193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimal heparin cofactor activity in disseminated intravascular coagulation and cirrhosis.
    Braunstein KM; Eurenius K
    Am J Clin Pathol; 1976 Sep; 66(3):488-94. PubMed ID: 60879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.